iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
16 Jun 2018
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma
EHA Topics in focus : Immunotherapy
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
EHA 2018: Results of the OPTIMISMM trial
First results of DREAM trial of frontline durvalumab for mesothelioma
International cancer control plans
Updates in melanoma from ASCO 2018
Finding appropriate doses for HER2 positive breast cancers
Education, collaboration and communication in global cancer control
New pathways in pancreatic cancer
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer